Logo image
Sign in
Back
Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients with Recurrent Clostridium difficile Infection
Journal article   Open access

Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients with Recurrent Clostridium difficile Infection

R. L. Patron, C. A. Hartmann, S. Allen, C. L. Griesbach, H. E. Kosiorek, J. K. Dibaise and R. Orenstein
Clinical Infectious Diseases, Vol.65(7)
2017
DOI: https://doi.org/10.1093/cid/cix511

Abstract

Clostridium difficile fecal microbiota transplantation FMT failure tapered oral vancomycin vancomycin antiinfective agent adult aged antibiotic therapy Article Clostridium difficile infection cohort analysis controlled study disease association drug dose reduction female human major clinical study male patient risk priority journal recurrent infection retrospective study tertiary care center treatment failure Clostridium infection drug effect feces microbiology microflora middle aged Peptoclostridium difficile physiology procedures recurrent disease risk factor treatment outcome very elderly young adult Aged, 80 and over Anti-Bacterial Agents Clostridium Infections Humans Microbiota Recurrence Retrospective Studies Risk Factors
url
https://doi.org/10.1093/cid/cix511View
Published (Version of record) Open

Metrics

2 Record Views

Details